TAYLOR AMBRUSO: Open Payments
NPI 1396439634 · SAINT PETERSBURG, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$326 in 16 payments from 7 companies in 2025. Trend: 2023 $73 · 2024 $258 · 2025 $326
Food & beverage: $326
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 5 | $130 |
| AstraZeneca Pharmaceuticals LP | 4 | $67 |
| Amgen Inc. | 2 | $39 |
| Phadia US Inc. | 2 | $33 |
| Xeris Pharmaceuticals, Inc. | 1 | $25 |
| Lilly USA, LLC | 1 | $19 |
| PFIZER INC. | 1 | $15 |
Products named: TRELEGY ELLIPTA, AIRSUPRA, REPATHA, ImmunoCAP, KEVEYIS, KISUNLA, PREVNAR 20.
Industry payments across FL — which companies pay providers there.
